Nasopharyngeal carcinoma is a common malignant tumor in the head and neck. Because of frequent recurrence and distant metastasis which are the main causes of death, better treatment is needed. Indole-3-carbinol (I3C), a natural phytochemical found in the vegetables of the cruciferous family, shows anticancer effect through various signal pathways. I3C induces G1 arrest in NPC cell line with downregulation of cell cycle-related proteins, such as CDK4, CDK6, cyclin D1 and pRb. In vivo, nude mice receiving I3C protectively or therapeutically exhibited smaller tumors than control group after they were inoculated with nasopharyngeal carcinoma cells. The expression of CDK4, CDK6, cyclin D1 and pRb in preventive treatment group and drug treatment group both decreased compared with the control group. We conclude that I3C can inhibit the growth of NPC in vitro and in vivo by suppressing the expression of CDK and cyclin families. The drug was safe and had no toxic effects on normal tissues and organs.
References
[1]
Lee AW, Sze WM, Au JS, Leung SF, Leung TW, et al. (2005) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61: 1107–1116.
[2]
Chan ATC (2010) Nasopharyngeal carcinoma. Annals of Oncology 21: vii308–vii312.
[3]
Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH (2001) Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 20: 2927–2936.
[4]
Nachshon-Kedmi M, Yannai S, Haj A, Fares FA (2003) Indole-3-carbinol and 3,3′-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 41: 745–752.
[5]
Hsu JC, Dev A, Wing A, Brew CT, Bjeldanes LF, et al. (2006) Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein. Biochem Pharmacol 72: 1714–1723.
[6]
Zhang J, Hsu BAJ, Kinseth BAM, Bjeldanes LF, Firestone GL (2003) Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells. Cancer 98: 2511–2520.
[7]
Takada Y, Andreeff M, Aggarwal BB (2005) Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 106: 641–649.
[8]
Wu HT, Lin SH, Chen YH (2005) Inhibition of cell proliferation and in vitro markers of angiogenesis by indole-3-carbinol, a major indole metabolite present in cruciferous vegetables. J Agric Food Chem 53: 5164–5169.
[9]
Aggarwal BB, Ichikawa H (2005) Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4: 1201–1215.
[10]
Ping J, Gao AM, Qin HQ, Wei XN, Bai J, et al. (2011) Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of kappaB kinase alpha/inhibitor of kappaB-alpha/nuclear factor-kappaB pathway. J Pharmacol Exp Ther 339: 694–703.
[11]
Ping J, Li JT, Liao ZX, Shang L, Wang H (2011) Indole-3-carbinol inhibits hepatic stellate cells proliferation by blocking NADPH oxidase/reactive oxygen species/p38 MAPK pathway. Eur J Pharmacol 650: 656–662.
[12]
Zhao P, Fu J, Yao B, Hu E, Song Y, et al. (2013) Diethyl sulfate-induced cell cycle arrest and apoptosis in human bronchial epithelial 16HBE cells. Chem Biol Interact 205: 81–89.
[13]
Wu A, Luo W, Zhang Q, Yang Z, Zhang G, et al. (2013) Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma. Cancer Lett 330: 181–189.
[14]
Yang Y, Liao Q, Wei F, Li X, Zhang W, et al. (2013) LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS One 8: e62869.
[15]
Han JB, Tao ZZ, Chen SM, Kong YG, Xiao BK (2011) Adenovirus-mediated transfer of tris-shRNAs induced apoptosis of nasopharyngeal carcinoma cell in vitro and in vivo. Cancer Lett 309: 162–169.
[16]
Wang Y, Tao ZZ, Chen SM, Xiao BK, Zhou XH, et al. (2008) Application of combination of short hairpin RNA segments for silencing VEGF, TERT and Bcl-xl expression in laryngeal squamous carcinoma. Cancer Biol Ther 7: 896–901.
[17]
Xie Y, Li Y, Peng X, Henderson F Jr, Deng L, et al.. (2013) Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-kappaB-independent and ERK-dependent pathway. Oral Oncol.
[18]
Teo PM, Kwan WH, Lee WY, Leung SF, Johnson PJ (1996) Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 77: 2423–2431.
[19]
Sham JS, Choy D, Choi PH (1990) Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure. Br J Radiol 63: 108–113.
[20]
Ma BB, Chan AT (2005) Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer 103: 22–31.
[21]
Marconett CN, Sundar SN, Tseng M, Tin AS, Tran KQ, et al. (2011) Indole-3-carbinol downregulation of telomerase gene expression requires the inhibition of estrogen receptor-alpha and Sp1 transcription factor interactions within the hTERT promoter and mediates the G1 cell cycle arrest of human breast cancer cells. Carcinogenesis 32: 1315–1323.
[22]
Choi H-S, Cho M-C, Lee HG, Yoon D-Y (2010) Indole-3-carbinol induces apoptosis through p53 and activation of caspase-8 pathway in lung cancer A549 cells. Food and Chemical Toxicology 48: 883–890.
[23]
Xu Y, Zhang J, Dong WG (2011) Indole-3-carbinol (I3C)-induced apoptosis in nasopharyngeal cancer cells through Fas/FasL and MAPK pathway. Med Oncol 28: 1343–1348.
[24]
Zhu W, Li W, Yang G, Zhang Q, Li M, et al. (2010) Indole-3-carbinol inhibits nasopharyngeal carcinoma. Int J Toxicol 29: 185–192.
[25]
Ye M, Luo X, Li L, Shi Y, Tan M, et al. (2007) Grifolin, a potential antitumor natural product from the mushroom Albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1/2 pathway. Cancer Lett 258: 199–207.
[26]
Liu DB, Hu GY, Long GX, Qiu H, Mei Q, et al. (2012) Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation. Acta Pharmacol Sin 33: 682–690.
[27]
Ong CS, Zhou J, Ong CN, Shen HM (2010) Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3beta-Cyclin D1 pathway. Cancer Lett 298: 167–175.
[28]
Hirama T, Koeffler HP (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86: 841–854.
[29]
Sherr CJ (1995) D-type cyclins. Trends Biochem Sci 20: 187–190.
[30]
Sherr CJ (1996) Cancer cell cycles. Science 274: 1672–1677.
[31]
Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, et al. (1996) Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12: 97–99.
[32]
Paggi MG, Baldi A, Bonetto F, Giordano A (1996) Retinoblastoma protein family in cell cycle and cancer: a review. J Cell Biochem 62: 418–430.
[33]
Zhang W, Zeng Z, Zhou Y, Xiong W, Fan S, et al. (2009) Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis. Acta Biochim Biophys Sin (Shanghai) 41: 414–428.
[34]
Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203–208.
[35]
Orlowski RZ, Baldwin AS Jr (2002) NF-kappaB as a therapeutic target in cancer. Trends Mol Med 8: 385–389.
[36]
Grose KR, Bjeldanes LF (1992) Oligomerization of indole-3-carbinol in aqueous acid. Chem Res Toxicol 5: 188–193.
[37]
Kim DS, Jeong YM, Moon SI, Kim SY, Kwon SB, et al. (2006) Indole-3-carbinol enhances ultraviolet B-induced apoptosis by sensitizing human melanoma cells. Cell Mol Life Sci 63: 2661–2668.
[38]
Chen DZ, Qi M, Auborn KJ, Carter TH (2001) Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium. J Nutr 131: 3294–3302.
[39]
Weng JR, Tsai CH, Kulp SK, Wang D, Lin CH, et al. (2007) A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells. Cancer Res 67: 7815–7824.
[40]
Moiseeva EP, Fox LH, Howells LM, Temple LA, Manson MM (2006) Indole-3-carbinol-induced death in cancer cells involves EGFR downregulation and is exacerbated in a 3D environment. Apoptosis 11: 799–812.
[41]
Anderton MJ, Jukes R, Lamb JH, Manson MM, Gescher A, et al. (2003) Liquid chromatographic assay for the simultaneous determination of indole-3-carbinol and its acid condensation products in plasma. J Chromatogr B Analyt Technol Biomed Life Sci 787: 281–291.
[42]
Reed GA, Arneson DW, Putnam WC, Smith HJ, Gray JC, et al. (2006) Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3′-diindolylmethane. Cancer Epidemiol Biomarkers Prev 15: 2477–2481.
[43]
Anderton MJ, Manson MM, Verschoyle RD, Gescher A, Lamb JH, et al. (2004) Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice. Clin Cancer Res 10: 5233–5241.
[44]
Reed GA, Peterson KS, Smith HJ, Gray JC, Sullivan DK, et al. (2005) A phase I study of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev 14: 1953–1960.
[45]
Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22: 659–661.
